Berenberg raises Wheaton Precious Metals stock price target on record Q2

Published 12/08/2025, 09:30
Berenberg raises Wheaton Precious Metals stock price target on record Q2

Investing.com - Berenberg raised its price target on Wheaton Precious Metals (NYSE:WPM) to C$78.00 from C$72.00 while maintaining a Buy rating following the company’s record quarterly earnings. According to InvestingPro data, the stock is currently trading near its 52-week high of $103.81, with analysts setting targets between $90 and $125.

Wheaton Precious Metals reported its Q2 results on August 7, delivering record quarterly earnings that exceeded Visible Alpha consensus estimates by 7% for adjusted EPS and 15% for operating cash flows.

The strong performance was attributed to a combination of higher production, sales volumes, realized prices, and margins, according to Berenberg.

Wheaton maintained its production guidance for 2025, with several near-term development streams progressing on track. Berenberg noted that execution of Wheaton’s expected 32% volume growth to 2028 (versus 2024) represents a key factor for continued share price appreciation.

The stock closed up 2.9% in London following the results announcement on August 7.

In other recent news, Wheaton Precious Metals reported exceptional financial results for the second quarter of 2025. The company achieved record revenue of $503 million, marking a 68% increase from the previous year and surpassing analysts’ expectations of $438.31 million by 14.76%. Additionally, Wheaton posted an earnings per share of $0.63, exceeding the forecasted $0.56 by 12.5%. Operating cash flow also saw a significant rise, reaching $415 million, up 77% from the same period last year. CFRA responded to these strong results by raising its price target for Wheaton Precious Metals to C$158.00 from C$132.00, while maintaining a Buy rating. The firm highlighted the company’s impressive second-quarter performance as a key factor in its decision. These developments reflect positively on Wheaton’s financial health and operational efficiency.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.